With major clinical milestones fast approaching, Vince will be a great asset as we seek to commercialise our products. Welcome Vince!
Taken from Botanix's facebook page. Obviously not a market announcement, so can't be taken as anything other than a sales pitch.
But wow are they confident. And these are industry leaders, with all the necessary credentials, proven track records and reputations on the line, to make me happy to read between the lines.
I can imagine there are numerous US based fund managers scratching their head saying , Vince joined what company?'
Interesting times ahead.
Milesy
With major clinical milestones fast approaching, Vince will be a...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
-0.025(6.58%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.5¢ | $924.4K | 2.553M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 654810 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 11.05am 25/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |